KYPHON® ACTIVOS¿ BONE CEMENT WITH HYDROXYAPATITE
Report
- Report Number
- 6000033-2024-00046
- Event Type
- Malfunction
- Date Received
- November 29, 2024
- Date of Event
- November 9, 2024
- Report Date
- November 29, 2024
- Manufacturer
- CARDIAC SURGERY MFG KERKRADE
- Product Code
- NDN
- PMA / PMN Number
- SEE H11
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IN
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
G2: COUNTRY OF ORIGIN IS I(B)(6). G3 PMA/510(K)#: THE REPORTED PRODUCT C05B IS NOT MARKETED IN US BUT A SIMILAR PRODUCT WITH PRODUCT ID: CX01A, UDI: (B)(4) WITH 510(K)# K102397 IS MARKETED IN US. MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.
INFORMATION WAS RECEIVED FROM MULTIPLE SOURCES (MANUFACTURER REPRESENTATIVE, HEALTHCARE PROVIDER) REGARDING A PRODUCT USED FOR SPINAL THERAPY. IT WAS REPORTED THAT THE MONOMER WAS ALREADY CRYSTALIZED WHILE OPENING THE PACK. THERE WAS NO PATIENT INVOLVEMENT REPORTED. THERE WERE NO FURTHER COMPLICATIONS REPORTED REGARDING THE EVENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2439726 | KYPHON® ACTIVOS¿ BONE CEMENT WITH HYDROXYAPATITE | CEMENT, BONE, VERTEBROPLASTY | NDN | CARDIAC SURGERY MFG KERKRADE | C05B | 229096428 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown |